Douglas Bolesch focuses his practice in litigation for the pharmaceutical and biotechnology industries. He joined the legal profession with more than 15 years of technical experience in biotechnology, having held research and research management positions at biopharmaceutical companies Chiron and Amgen. His industry experience includes large molecules, small molecules, vaccines, and all phases of development from research through commercial launch.
Background and Credentials
Dr. Bolesch received his J.D., magna cum laude, from Santa Clara University School of Law where he was also awarded the Order of the Coif. As a law student, Dr. Bolesch received both Witkin and CALI awards for his legal writing. He completed internships at DNA-microarray company Affymetrix, and at the University of California, San Francisco (UCSF), Office of Technology Management.
He holds a Ph.D. in chemical engineering from the University of California, Berkeley. His graduate thesis, titled “Polyphosphate Binding and Chain-Length Recognition of E. coli Exopolyphosphatase,” involved determining the mechanism for expolyphosphatase processivity and biopolymer-chain-length recognition. As a graduate student, his research was supported through a biotechnology fellowship from the National Institutes of Health. He holds a B.S. degree in chemistry from Purdue University.
- Santa Clara University School of Law (J.D., magna cum laude)
- University of California, Berkeley (Ph.D.)
- Chemical Engineering
- Purdue University (B.S., summa cum laude)
- U.S. Patent and Trademark Office
Publications and Presentations
- "Obviousness-Type Double Patenting Does Not Invalidate a Patent Term Extension," Marshall Gerstein Alert, December 12, 2018.